Here is a summary of the clinical note:

**Patient Information:**

* Name: [Not provided]
* Date of Birth: [Not provided]
* Sex: Male
* Unit No: [Not provided]
* Admission Date: [Not provided]
* Discharge Date: [Not provided]

**Chief Complaint:**

* Anasarca (generalized edema)

**Medical History:**

* Pancreatic adenocarcinoma metastatic to the liver (biopsy-proven)
* Type 2 diabetes mellitus (T2DM)
* Hypertension (HTN)
* Hyperlipidemia
* Dyslipidemia (DL)
* Left hip replacement
* Heart murmur
* Nose fracture
* Kidney lesion (2.4cm hemmorhagic cyst)

**Cancer History:**

* Diagnosed with pancreatic adenocarcinoma in [Not provided]
* Treated with FOLFIRINOX, gemcitabine, and erlotinib
* Disease progressed with increased size of liver metastases

**Current Status:**

* Currently on C1D10 gemcitabine and erlotinib
* Recent biliary sepsis, stent, and completed antibiotic course for Klebsiella bacteremia
* Leaking paracentesis site on the left lower quadrant (LLQ) and increased anasarca with bilateral pedal edema
* New asymptomatic bilateral pleural effusions

**Diagnostic Tests:**

* CT scan showed progression of disease with increased size of innumerable hepatic masses, increased abnormal soft tissue in the retroperitoneum, and increasing ascites
* MRI liver showed progression of disease
* CT chest showed new irregular nodule in the right upper lobe and interval increase of the right lower lobe nodules concerning for progressive metastatic disease
* ERCP showed a 3.5 cm x 4 cm ill-defined mass in the head of the pancreas, involving the confluence, especially the SMV with narrowing of vessel diameter

**Surgical Interventions:**

* Therapeutic paracentesis with stitches placed to stop the leaking

**Medications:**

* Gemcitabine
* Erlotinib
* Capecitabine (Xeloda)
* Tarceva
* Furosemide (Lasix)
* Spironolactone (Aldactone)
* Amlodipine
* Lisinopril
* Metformin (Glucophage XR)
* Creon
* Duloxetine
* Methylphenidate (Ritalin)
* Pyridoxine
* Simethicone
* Tamsulosin
* Nystatin oral suspension
* Lorazepam (Ativan)

**Discharge Status:**

* Discharged home with service
* Follow-up with primary oncologist and PCP
* Continue chemotherapy as planned